INCUBATING PROJECT | DECENTRALIZED TRIALS PLATFORM

IoT & Personalized Medicines

Leverages blockchain in combination with Machine Learning and Artificial Intelligence to create algorithms capable of improving healthcare provision

This project’s objective is to provide dynamic acquisition and processing of data from patient Real World Data (RWD) sources to accelerate clinical development and enable Remote Patient Monitoring (RPM) .

This introduces new rights for patient data ownership and portability, and leverages dynamic consent while using device-generated data in compliance with data privacy regulations.

IoT & Personalized Medicines

TRL Readiness

Sandbox Idea

TRL 0

Dive in this Project

Clinical Trial & Health Data Use Case Presentations

PharmaLedger’s 2nd Open Webinar

Blockchain-Powered Clinical Trials: Patient Centricity

PharmaLedger’s 5th Open Webinar

Joining PLA

As a Member Company:

By joining the PharmaLedger Association, you’ll become a key player in a collaborative network actively tackling systemic challenges.

As a Individual:

PLA is the venue for collaboration to incubate, develop, and launch Healthcare 4.0 products. While Membership is limited to registered entities individuals can also engage as contributors in the xLab without any fees.

Membership in PLA allows you to:

  • Receive qualified and fully tested solutions
  • Pool resources and risk with like-minded partners to realize increased benefits
  • Promote your existing solutions within the PLA network
  • Make decisions on the prioritization of our solution pipeline
  • Operate a node on the PLA network to strengthen trust and resiliency

Join our PLA Collaboration Platform if you want to contribute contribute funding and expertise to the xLab program and have access to exclusive content in our xLab Strategic Working Groups.

Members, non-member organizations and expert individuals alike are all welcome.

The symbol of PharmaLedger, a modernized white version of the Vitruvian Man.

Sign up for our newsletter

    All Rights Reserved © 2025 PharmaLedger Association